Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / PHARMACEUTICALS
-
Number of holders
-
83
-
Total 13F shares, excl. options
-
750,950
-
Shares change
-
-45,579
-
Total reported value, excl. options
-
$59,765,049
-
Value change
-
-$3,608,649
-
Number of buys
-
31
-
Number of sells
-
32
-
Price
-
$79.59
Institutional Holders of INVESCO EXCHANGE TRADED FD T - PHARMACEUTICALS (PJP) as of Q1 2022
As of 31 Mar 2022 INVESCO EXCHANGE TRADED FD T - PHARMACEUTICALS (PJP) had 83 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 750,950 shares of stock of the company.
Largest 10 holders included Peak Asset Management, LLC, LPL Financial LLC, BANK OF AMERICA CORP /DE/, GOLDMAN SACHS GROUP INC, UBS Group AG, MORGAN STANLEY, Federation des caisses Desjardins du Quebec, COMMONWEALTH EQUITY SERVICES, LLC, WELLS FARGO & COMPANY/MN, and U.S. Capital Wealth Advisors, LLC.
This table shows 83 institutional shareholders of the security as of 31 Mar 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.